Clinical trial
Evaluation of Multiple Biomarkers in Serum and Pleural Fluid to Estimate the Probability of Cancer in Patients Presenting With an Undiagnosed Pleural Effusion
NCT00316134 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Multiple Biomarkers in Serum and Pleural Fluid to Estimate the Probability of Cancer in Patients Presenting With an Undiagnosed Pleural Effusion
- Lead sponsor
- Fujirebio Diagnostics, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 31, 2006
- Completion date
- February 29, 2008
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.